Home > Healthcare > Medical Devices > Medical Supplies > Laparotomy Sponges Market
Laparotomy Sponges Market size is projected to expand at a substantial rate from 2024 to 2032, led by wide range of advantages, such as safety, reliability, and ease of performance. Of late, the incidences of colonic volvulus and other gastrointestinal disorders is significantly rising among adults. This scenario will boost the need for surgeries and in turn, improve the adoption of laparotomy sponges.
The higher prevalence of abdominal disorders, such as colon cancer and appendicitis, will further drive the market gains during the analysis timeframe. According to the American Cancer Society, in 2022, the U.S. was estimated to record 106,180 new cases of colorectal cancer. This factor is predicted to stimulate the usage of sterile laparotomy sponges to remove colon tumors. However, high preference for non-invasive surgeries and the growing awareness of the benefits of alternative surgical procedures, such as reduced pain and faster recovery, may hamper the industry expansion to some extent.
The market is likely to grow with the increasing number of women diagnosed with ovarian cancer in European countries. According to the European Society for Medical Oncology (ESMO), in 2022, 26,500 women were predicted to die from ovarian cancer in the EU. This trend is expected to continue in 2024. To that end, the growing adoption of surgical lap sponges in exploratory laparotomy surgeries will add to the product uptake.
According to WHO, one-sixth of the global population will be aged 60 years or older by 2030, with the number increasing from 1 billion in 2020 to 1.4 billion. By 2050, this population base is projected to double, reaching 2.1 billion. The trend of the rising geriatric population will increase the chances of colorectal cancer in the adult population.
The market is bifurcated into sterile and non-sterile sponges. The industry revenue from sterile laparotomy sponges is set to grow exponentially from 2024 to 2032. Sterile sponges, which are generally used to treat highly exudative and dirty wounds, possess superior absorption properties, and offer great comfort to patients. These sponges also prevent the risks of cross contamination and can effectively control excessive bleeding.
In terms of end-use, the laparotomy sponges market value from the surgical center segment is projected to rise at substantial CAGR through 2032. One of the key factors fueling the preference for these centers is the rising inclination towards outpatient surgical procedures to treat digestive disorders, such as hemorrhoids, which affects millions of Americans every year. Nearly 10.4 million people in the U.S. suffer from hemorrhoids, with 1 million new cases recorded each year. This trend can increase the usage of laparotomy sponges.
The North America laparotomy sponges market size is anticipated to grow at substantial CAGR from 2024 to 2032. The growth can be attributed to the rising number of surgical procedures, increasing prevalence of chronic diseases, and the rising adoption of laparotomy sponges in healthcare facilities. Technological advancements in sponge design, enhanced patient safety, and the high demand for minimally invasive surgeries will favor the regional progression. Moreover, the influx of stringent regulations for promoting the use of sterile surgical products.
Some of the major laparotomy sponges companies are:
Prominent laparotomy sponges industry players are concentrating their efforts on adopting inorganic market strategies, such as partnerships, mergers, and acquisitions as well as launching new products in the market to gain competitive edges. For instance, Stryker has evolved as one of the leading medical technology companies in the world, committed to providing better healthcare solutions for its customers.